Personal tools

Coexpression cluster:C371: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|gostat_on_coexpression_clusters=GO:0008559!xenobiotic-transporting ATPase activity!0.0035321647640094!5243$GO:0042910!xenobiotic transporter activity!0.0035321647640094!5243$GO:0015239!multidrug transporter activity!0.0035321647640094!5243$GO:0015238!drug transporter activity!0.0145663193763842!5243$GO:0042493!response to drug!0.0333499698628189!5243
|gostat_on_coexpression_clusters=GO:0008559!xenobiotic-transporting ATPase activity!0.0035321647640094!5243$GO:0042910!xenobiotic transporter activity!0.0035321647640094!5243$GO:0015239!multidrug transporter activity!0.0035321647640094!5243$GO:0015238!drug transporter activity!0.0145663193763842!5243$GO:0042493!response to drug!0.0333499698628189!5243
|id=C371
|id=C371
|ontology_enrichment_celltype=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0007023!2.01e-68!115;UBERON:0001049!1.59e-39!57;UBERON:0005068!1.59e-39!57;UBERON:0006241!1.59e-39!57;UBERON:0007135!1.59e-39!57;UBERON:0005743!9.43e-37!86;UBERON:0001017!1.33e-36!82;UBERON:0002616!2.79e-35!59;UBERON:0000073!3.14e-33!94;UBERON:0001016!3.14e-33!94;UBERON:0003080!2.44e-32!42;UBERON:0002780!1.27e-31!41;UBERON:0001890!1.27e-31!41;UBERON:0006240!1.27e-31!41;UBERON:0000955!3.41e-31!69;UBERON:0006238!3.41e-31!69;UBERON:0003075!5.30e-31!86;UBERON:0007284!5.30e-31!86;UBERON:0002346!2.53e-29!90;UBERON:0002020!6.60e-27!34;UBERON:0003528!6.60e-27!34;UBERON:0001893!1.37e-26!34;UBERON:0002791!7.90e-26!33;UBERON:0001869!3.39e-25!32;UBERON:0003056!1.52e-21!61;UBERON:0000956!1.62e-19!25;UBERON:0000203!1.62e-19!25;UBERON:0000153!1.71e-19!129;UBERON:0007811!1.71e-19!129;UBERON:0002619!7.20e-19!22;UBERON:0004121!1.32e-18!169;UBERON:0000033!1.88e-18!123;UBERON:0000924!5.34e-18!173;UBERON:0006601!5.34e-18!173;UBERON:0001950!3.78e-17!20;UBERON:0004111!3.35e-13!241;UBERON:0000025!4.71e-13!194;UBERON:0000477!9.35e-12!286;UBERON:0002420!5.55e-09!9;UBERON:0007245!5.55e-09!9;UBERON:0010009!5.55e-09!9;UBERON:0010011!5.55e-09!9;UBERON:0000454!5.55e-09!9;UBERON:0000481!6.58e-09!347;UBERON:0002308!7.71e-09!9;UBERON:0000125!7.71e-09!9;UBERON:0003076!1.93e-08!15;UBERON:0003057!1.93e-08!15;UBERON:0000119!3.16e-08!312;UBERON:0000483!7.25e-08!309;UBERON:0002298!1.40e-07!8;UBERON:0001871!1.44e-07!7;UBERON:0000062!2.33e-07!511;UBERON:0009663!3.16e-07!7;UBERON:0000468!3.50e-07!659;UBERON:0000922!4.34e-07!612;UBERON:0000467!5.27e-07!625;UBERON:0000480!6.71e-07!626;UBERON:0000064!7.96e-07!219
}}
}}

Revision as of 14:39, 21 May 2012


Full id: C371_occipital_medial_brain_parietal_amygdala_frontal_olfactory



Phase1 CAGE Peaks

Hg19::chr4:88411966..88411977,-p@chr4:88411966..88411977
-
Hg19::chr4:88414835..88414843,-p@chr4:88414835..88414843
-
Hg19::chr4:88415052..88415063,-p@chr4:88415052..88415063
-
Hg19::chr4:88415241..88415254,-p@chr4:88415241..88415254
-
Hg19::chr4:88415266..88415276,-p@chr4:88415266..88415276
-
Hg19::chr4:88415315..88415329,-p@chr4:88415315..88415329
-
Hg19::chr4:88415383..88415404,-p@chr4:88415383..88415404
-
Hg19::chr4:88415409..88415444,-p@chr4:88415409..88415444
-
Hg19::chr4:88415461..88415473,-p@chr4:88415461..88415473
-
Hg19::chr4:88415581..88415589,-p@chr4:88415581..88415589
-
Hg19::chr4:88415590..88415607,-p@chr4:88415590..88415607
-
Hg19::chr4:88415610..88415627,-p@chr4:88415610..88415627
-
Hg19::chr4:88415629..88415646,-p@chr4:88415629..88415646
-
Hg19::chr4:88415711..88415725,-p@chr4:88415711..88415725
-
Hg19::chr4:88415731..88415754,-p@chr4:88415731..88415754
-
Hg19::chr4:88416158..88416167,-p@chr4:88416158..88416167
-
Hg19::chr4:88416205..88416281,-p@chr4:88416205..88416281
-
Hg19::chr4:88450273..88450287,-p5@SPARCL1
Hg19::chr4:88450351..88450368,-p2@SPARCL1
Hg19::chr4:88450372..88450424,-p3@SPARCL1
Hg19::chr4:88450428..88450439,-p9@SPARCL1
Hg19::chr4:88450448..88450459,-p7@SPARCL1
Hg19::chr4:88450511..88450533,-p1@SPARCL1
Hg19::chr4:88450535..88450561,-p4@SPARCL1
Hg19::chr4:88450595..88450608,-p6@SPARCL1
Hg19::chr4:88450612..88450623,-p8@SPARCL1
Hg19::chr4:88451026..88451042,-p15@SPARCL1
Hg19::chr7:87338767..87338774,+p2@RUNDC3B
Hg19::chr7:87342602..87342617,-p2@ABCB1
Hg19::chr7:87342681..87342695,-p3@ABCB1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0008559xenobiotic-transporting ATPase activity0.0035321647640094
GO:0042910xenobiotic transporter activity0.0035321647640094
GO:0015239multidrug transporter activity0.0035321647640094
GO:0015238drug transporter activity0.0145663193763842
GO:0042493response to drug0.0333499698628189



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
adult organism2.01e-68115
neural tube1.59e-3957
neural rod1.59e-3957
future spinal cord1.59e-3957
neural keel1.59e-3957
central nervous system1.33e-3682
regional part of brain2.79e-3559
regional part of nervous system3.14e-3394
nervous system3.14e-3394
anterior neural tube2.44e-3242
regional part of forebrain1.27e-3141
forebrain1.27e-3141
future forebrain1.27e-3141
brain3.41e-3169
future brain3.41e-3169
neural plate5.30e-3186
presumptive neural plate5.30e-3186
neurectoderm2.53e-2990
gray matter6.60e-2734
brain grey matter6.60e-2734
telencephalon1.37e-2634
regional part of telencephalon7.90e-2633
cerebral hemisphere3.39e-2532
pre-chordal neural plate1.52e-2161
cerebral cortex1.62e-1925
pallium1.62e-1925
anterior region of body1.71e-19129
craniocervical region1.71e-19129
regional part of cerebral cortex7.20e-1922
ectoderm-derived structure1.32e-18169
head1.88e-18123
ectoderm5.34e-18173
presumptive ectoderm5.34e-18173
neocortex3.78e-1720
anatomical conduit3.35e-13241
tube4.71e-13194
anatomical cluster9.35e-12286
basal ganglion5.55e-099
nuclear complex of neuraxis5.55e-099
aggregate regional part of brain5.55e-099
collection of basal ganglia5.55e-099
cerebral subcortex5.55e-099
multi-tissue structure6.58e-09347
nucleus of brain7.71e-099
neural nucleus7.71e-099
posterior neural tube1.93e-0815
chordal neural plate1.93e-0815
cell layer3.16e-08312
epithelium7.25e-08309
brainstem1.40e-078
temporal lobe1.44e-077
organ2.33e-07511
telencephalic nucleus3.16e-077
multi-cellular organism3.50e-07659
embryo4.34e-07612
anatomical system5.27e-07625
anatomical group6.71e-07626
organ part7.96e-07219


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.